Sequential Digestion with Trypsin and Elastase in Cross-Linking Mass Spectrometry by Dau, Therese et al.
                          Dau, T., Gupta, K., Berger, I., & Rappsilber, J. (2019). Sequential Digestion
with Trypsin and Elastase in Cross-Linking Mass Spectrometry. Analytical
Chemistry, 91(7), 4472-4478. https://doi.org/10.1021/acs.analchem.8b05222
Publisher's PDF, also known as Version of record
License (if available):
CC BY
Link to published version (if available):
10.1021/acs.analchem.8b05222
Link to publication record in Explore Bristol Research
PDF-document
This is the final published version of the article (version of record). It first appeared online via ACS at
https://doi.org/10.1021/acs.analchem.8b05222 . Please refer to any applicable terms of use of the publisher.
University of Bristol - Explore Bristol Research
General rights
This document is made available in accordance with publisher policies. Please cite only the published
version using the reference above. Full terms of use are available:
http://www.bristol.ac.uk/pure/about/ebr-terms
Sequential Digestion with Trypsin and Elastase in Cross-Linking
Mass Spectrometry
Therese Dau,† Kapil Gupta,‡ Imre Berger,‡ and Juri Rappsilber*,†,§
†Wellcome Centre for Cell Biology, Institute of Cell Biology, School of Biological Sciences, University of Edinburgh, Edinburgh EH9
3BF, United Kingdom
‡BrisSynBio Centre, The School of Biochemistry, Faculty of Biomedical Sciences, University of Bristol, Bristol BS8 1TD, United
Kingdom
§Bioanalytics, Institute of Biotechnology, Technische Universitaẗ Berlin, 13355 Berlin, Germany
ABSTRACT: Cross-linking mass spectrometry has become an important approach
for studying protein structures and protein−protein interactions. The amino acid
compositions of some protein regions impede the detection of cross-linked residues,
although it would yield invaluable information for protein modeling. Here, we report
on a sequential-digestion strategy with trypsin and elastase to penetrate regions with a
low density of trypsin-cleavage sites. We exploited intrinsic substrate-recognition
properties of elastase to speciﬁcally target larger tryptic peptides. Our application of
this protocol to the TAF4−12 complex allowed us to identify cross-links in previously
inaccessible regions.
Trypsin is the enzyme of choice in mass-spectrometry(MS)-based proteomics. The favorable behavior of
tryptic peptides during mass-spectrometric analysis is one of
the main reasons for this.1,2 However, as trypsin cleaves after
Arg and Lys, peptides generated in protein regions with a low
Arg and Lys densities are very long, making them potentially
nonobservable by mass spectrometry and thus resulting in poor
coverage of those regions.
This problem is particularly relevant for cross-linking mass
spectrometry (CLMS). In CLMS, protein proximities and
conformations are preserved through the introduction of
covalent bonds. The detection of these bonds as cross-linked
peptide pairs by MS is translated into distance constraints.3−7
Currently, the most frequently used cross-linkers are N-
hydroxysuccinimide (NHS) esters that primarily target the ε-
amino groups of Lys residues and to a lesser extent also react
with the hydroxyl groups of Ser, Thr, and Tyr.8,9 CLMS
critically depends on good sequence coverage to reveal
structural information for the whole protein. Cross-linking
naturally involves two peptides, which aggravates the problem
of overly large peptides. This is exacerbated when the cross-
linker reacts with two lysine residues as two potential cleavage
sites for trypsin are removed. The stabilization of proteins
through cross-linking and the destruction of potential trypsin-
cleavage sites may further aﬀect the eﬃciency of trypsin
digestion and lead to an increase in missed cleavages.
Alternative proteases to trypsin target basic (LysC and
ArgC), acidic (AspN and GluC), or aromatic (chymotrypsin)
amino acids.10,11 Although usage of these proteases improves
sequence coverage12,13 and has been used in parallel to usage
of trypsin to enhance identiﬁcation of cross-linked resi-
dues,14,15 some protein regions, such as the N-terminal region
of TAF4, a subunit of transcriptional factor II D, still cannot be
accessed (Figure 1). The existence of TAF4b, a cell-type-
speciﬁc TAF4 paralogue with a unique N-terminal region,
points to important functions and interactions mediated
through the N-terminal region of TAF4.16 Cross-linked
residues in this region would therefore provide important
information on the function and structure of TAF4.
Proteases with broader speciﬁcity, like elastase, proteinase K,
and pepsin, have the potential of complementing more
selective proteases and indeed have been used in membrane
proteomics17,18 to detect phosphorylation sites19 and even in
CLMS20 with varying levels of success. Elastase, for example,
cleaves after Ala, Val, Leu, Ile, Ser, and Thr17 and should be
able to cleave the N-terminal region of TAF4 at many sites
(Figure 1). This broad speciﬁcity leads to two potential
problems. If cleavage is complete, the resulting peptides would
be very small. However, cleavage of elastase is not expected to
be complete. Analyses of elastase eﬃciency on peptides with
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Figure 1. Theoretical cleavage sites in TAF4.
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varying length revealed elastase to have an extended substrate-
binding region.21,22 Short peptides that do not cover the
complete substrate-binding region are less eﬃciently cleaved
by elastase. Although this addresses the potential problem of
peptide length, it leads to another problem. Having many
missed cleavage sites leads elastase to generate very complex
mixtures with often overlapping peptides.17 This problem is
exacerbated in cross-linked peptides, as two peptides are
involved, resulting in a combinatorial increase of complexity.
Recent work by our lab revealed a strong substrate preference
of proteases for longer peptides.15 As a consequence, in a
sequential digest, preferentially long peptides are cleaved by
the second protease, whereas short peptides remain
undigested. The complexity of an elastase digest might
therefore be vastly reduced by ﬁrst using trypsin. Only long
tryptic peptides should be good substrates for elastase, whereas
any sequence range of a protein that is covered by short tryptic
peptides would remain unaﬀected by elastase treatment.
In this study, we investigate the hypothesis whether the
sequential digestion of trypsin and elastase might positively
impact the use of elastase in CLMS. As a result, we detected
cross-links in the diﬃcult-to-digest N-terminal region of TAF4.
■ MATERIALS AND METHODS
Sample Preparation. The human TAF4−TAF12 complex
was coexpressed in Sf21 insect cells using the MultiBac
system.23 DNA encoding an N-terminal hexa-histidine tag and
a protease-cleavage site for tobacco etch virus (TEV) NIa
protease was added to the 5′ end of the TAF4 open reading
frame and cloned into pFL plasmid along with TAF12.
Baculovirus generation, cell-culture infection, and protein
production were carried out following published protocols.24
Cell pellets were resuspended in Talon Buﬀer A (25 mM Tris
pH 8.0, 150 mM NaCl, 5 mM imidazole, and complete
protease inhibitor; Roche Molecular Biochemicals). Cells were
lysed by freeze−thawing (twice), followed by centrifugation at
40 000g in a Ti70 rotor for 60 min to clear the lysate. The
TAF4−TAF12 complex was ﬁrst bound to talon resin and pre-
equilibrated with Talon Buﬀer A; this was followed by washes
with Talon Buﬀer A, then with Talon Buﬀer HS (25 mM Tris
pH 8.0, 1 M NaCl, 5 mM imidazole, and complete protease
inhibitor), and then again with Talon Buﬀer A. The TAF4−
TAF12 complex was eluted using Talon Buﬀer B (25 mM Tris
pH 8.0, 150 mM NaCl, 200 mM imidazole, and complete
protease inhibitor). Fractions containing the TAF4−TAF12
complex were dialyzed overnight against MonoQ Buﬀer A (25
mM HEPES, pH 7.5, 100 mM NaCl, 1 mM DTT, and
complete protease inhibitor). The complex was further puriﬁed
using ion-exchange chromatography (IEX) with a MonoQ
column pre-equilibrated with MonoQ Buﬀer A. After binding,
the column was washed with MonoQ Buﬀer A, and TAF4−
TAF12 was eluted using a continuous, linear gradient of
MonoQ Buﬀer B (25 mM HEPES pH 7.5, 1000 mM NaCl, 1
mM DTT, and complete protease inhibitor) from 0 to 100%.
The complex was further puriﬁed by size-exclusion chromatog-
raphy (SEC) with a SuperoseS6 10/300 column in SEC buﬀer
(25 mM Tris pH 8.0, 150 mM NaCl, 1 mM DTT, and
complete protease inhibitor).
TAF4−TAF12 (1.5 μg per condition) complexes were cross-
linked with bis(sulfosuccinimidyl)suberate (BS3) (Thermo
Fisher Scientiﬁc) at ratio of 1:1 (w/w) and incubated on ice
for 2 h. The mixture was incubated on ice for 1 h after
saturated bicarbonate (50 molar excess) was added to quench
the reaction. Frozen Schizosaccharomyces pombe cells were
ground, and 1 g of yeast powder was resuspended in 2 mL of
RIPA (Sigma-Aldrich) supplemented with cOmplete (Roche).
Cell debris was moved via centrifugation at 1200g for 15 min.
All samples were separated by SDS-PAGE on a 4−12% Bis
Tris gel (Life Technologies) and stained using Imperial
Protein Stain (Thermo Fisher Scientiﬁc). Appropriate bands
were cut and proteins were ﬁrst reduced with DTT and then
alkylated with iodoacetamide. Samples were incubated with
trypsin (13 ng μL−1; Pierce, Thermo Fisher Scientiﬁc) or
elastase (15 ng μL−1, Promega) at 37 °C for 16 h. In the case
of the elastase−trypsin digestion, trypsin (13 ng μL−1) was
added to the overnight elastase digest and incubated for 4 h at
room temperature. For the sequential trypsin−elastase
digestion, elastase (15 ng μL−1) was added to the trypsin
digest and incubated at 37 °C for 30 min. A comparison
between 30 min and 4 h of digestion with elastase showed no
signiﬁcant diﬀerence (data not shown). Following the
digestion, peptides were puriﬁed on C18 StageTips using
standardized protocols.25
LC-MS/MS. TAF4−TAF12 complexes were analyzed on an
Orbitrap Fusion Lumos Tribrid (Thermo Fisher Scientiﬁc)
and yeast lysates were analyzed on an Orbitrap Elite (Thermo
Fisher Scientiﬁc). Both were coupled online to an Ultimate
3000 RSLCnano Systems (Dionex, Thermo Fisher Scientiﬁc).
Peptides were loaded onto an EASY-Spray LC Column
(Thermo Fisher Scientiﬁc) at a ﬂow rate of 0.300 μL min−1
using 98% mobile phase A (0.1% formic acid) and 2% mobile
phase B (80% acetonitrile in 0.1% formic acid). To elute the
peptides, the percentage of mobile phase B was ﬁrst increased
to 40% over a time course of 110 min followed by a linear
increase to 95% in 11 min.
Full MS scans for yeast lysates were recorded in the orbitrap
at 120 000 resolution for MS1 with a scan range of 300−1700
m/z. The 20 most intense ions (precursor charge ≥2) were
selected for fragmentation by collision-induced disassociation,
and MS2 spectra were recorded in the ion trap (2.0 × 104 ions
as a minimal required signal, 35 normalized collision energy,
dynamic exclusion for 40 s). Both MS1 and MS2 were
recorded in the orbitrap for the TAF4−TAF12 complexes
(120 000 mass resolution for MS1 and 15 000 mass resolution
for MS2, scan range 300−1700 m/z, dynamic exclusion for 60
s, precursor charge ≥3). Higher-energy collision dissociation
was used to fragment peptides (30% collision energy, 5.0 × 104
AGC target, 60 ms maximum injection time).
Data Analysis. MaxQuant software26 (version 1.5.2.8)
employing the Andromeda search engine27 was used to analyze
the whole-cell lysates of S. Pombe. We used the PombeBase
database28 with carbamidomethylation of cysteine as a ﬁxed
modiﬁcation and oxidation of methionine as a variable
modiﬁcation. MS accuracy was set to 4.5 ppm and MS/MS
tolerance to 20 ppm. For trypsin, we allowed up to two
miscleavages. Speciﬁcity of elastase was deﬁned as cleavage
after Ala, Val, Leu, Ile, Ser, and Thr but not before Pro.
Speciﬁcity for the trypsin and elastase digest was set to
cleavage after Ala, Val, Leu, Ile, Ser, Thr, Arg, and Lys except if
it was followed by Pro. For all digests containing elastase, up to
10 miscleavages were allowed. The peaklist for identiﬁcation of
cross-linked peptides was generated using MS convert
(ProteoWizard) for tryptic digests with the following settings:
peakPicking: 2−, msLevel: 2−, MS2Denoise: 20 100, false or
Maxquant version 1.6.2.3 with default settings except
increasing the “Top MS/MS peaks per 100 Da” to 100 for
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elastase-containing digests. Resulting MGF or APL ﬁles were
searched using Xi software15,29 version 1.6.731 with MS
accuracy set to 4 ppm and MS/MS tolerance set to 20 ppm.
The only ﬁxed modiﬁcation was the carbamidomethylation of
cysteine. Variable modiﬁcations were the oxidation of
methionine and amidated and hydrolyzed BS3. The cross-
linker was BS3 with Lys, Ser, Thr, and Tyr as the only cross-
linkable residues. Enzyme speciﬁcities were the same as
described for Mascot. Four miscleavages were allowed for
the trypsin digest, and 11 miscleavages were allowed for the
other digests. Two additional missing isotopes were allowed in
the custom settings. False-discovery rates (FDR) were
estimated using xiFDR30 version 1.1.26.58 with 5% FDR at a
peptide-pair level for the TAF4−12 complex and 5% FDR at a
peptide-pair and -link level. Linear peptides of the cross-linked
TAF4−12 complex were identiﬁed using Mascot software31
with carbamidomethylation of cysteine as a ﬁxed modiﬁcation
and the following variable modiﬁcations: oxidation of
methionine, hydrolyzed BS3 (mass: 156.0786 Da), and
amidated BS3 (mass: 155.0946 Da). Chromatograms of MS1
were extracted, and peak areas were quantiﬁed using Skyline.32
In-Silico Digest. TheTAF4−TAF12 complex was digested
in-silico using trypsin, elastase or a combination of trypsin and
elastase. We assumed a complete digestion with no
miscleavages for the in-silico digestion and a minimum length
of ﬁve amino acids.
Random Distribution. Random links were generated
between cross-linkable residues. The links were ﬁtted into
the crystal structure of monomeric HSA (PDB: 1AO6) to
calculate the distances.
■ RESULTS AND DISCUSSION
Four diﬀerent types of digestion, trypsin, elastase, sequential
trypsin−elastase, and sequential elastase−trypsin, were applied
to a cross-linked TAF4−TAF12 complex. We compared these
digests to assess the inﬂuence of substrate length on the
cleavage behavior of elastase. The peptide lengths of the
observed tryptic peptides without any modiﬁcations ranged
from 5 to 65 amino acids, which are very similar to the
theoretical peptide-length distribution (Figure 2a). However,
the median lengths of the peptides digested by elastase,
trypsin−elastase, and elastase−trypsin were considerably
higher (12 amino acids) than the predicted medians of 6
amino acids (Figure 2b−d). The majority of elastase-derived
peptides are larger than 5 amino acids, and the maximal length
of 29 amino acids is considerably shorter than that of trypsin
(65). These observations are in line with previous studies on
short peptides reporting that the activity of elastase is
dependent on the substrate length N-terminal of the cleavage
site.21,22 Our results suggest that a similar restriction might also
apply to longer peptides and to the substrate length C-terminal
from the cleavage site.
Notably fewer peptide-spectrum matches (546 ± 74 PSM)
were identiﬁed following elastase digestion compared with
those from peptides digested by trypsin alone (869 ± 170
PSM), trypsin−elastase (1116 ± 164 PSM), or elastase−
trypsin (1111 ± 100 PSM, Figure 2e). One possible
explanation for the reduced identiﬁcation of elastase peptides
could be the missing positive C-terminal charge that tryptic
peptides have. To this end, we analyzed semitryptic peptides,
as they should distribute equally among those featuring a
tryptic C-terminus and a tryptic N-terminus. Semitryptic
peptides with tryptic C-termini were identiﬁed more often (70
Figure 2. Impact of elastase when following trypsin in a sequential
digestion of the TAF4−TAF12 complex. (a−d) Peptide-length
distribution of observed and theoretical peptides (full cleavage, no
modiﬁcations) for trypsin (a), elastase (b), sequential trypsin−
elastase (c), and sequential elastase−trypsin (d) digestion. (e)
Number of peptide-spectrum matches (PSM) for diﬀerent proteases
using Mascot. (f) Distribution of detected semitryptic peptides into
those with a tryptic C-terminus versus those with a tryptic N-terminus
in the sequential trypsin−elastase digest. (g) Intensity diﬀerences for
tryptic peptides in the tryptic digest and in the sequential trypsin−
elastase digest, determined using label-free quantitation in Skyline.
The peptides were divided into three groups depending on their
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± 2%), in agreement with a positive C-terminal charge being
beneﬁcial for detection (Figure 2f). Another disadvantage of
elastase is that it frequently misses cleavage sites and
overlapping peptides lead to complex peptide mixtures. By
digesting proteins with trypsin ﬁrst, the amount of available
cleavage sites for elastase might be reduced, as short tryptic
peptides should be protected from elastase because of their
size. The products of digested small peptides may not be
identiﬁed, because of the identiﬁcation bias against small
peptides that occurs in LC-MS/MS. To avoid this, we
quantiﬁed tryptic peptides before and after the addition of
elastase. Peptides that had been reduced by more than half
were labeled as “reduced”. The remaining peptides were
categorized as “unchanged”. Peptides were divided into three
groups depending on their lengths (≤12, 13−20, and >20).
The number of reduced peptides, 19, 70, or 113 peptides,
respectively, increased with peptide size (Figure 2g). The label-
free quantiﬁcation conﬁrms that elastase preferentially digests
long peptides; thus, initial trypsin digestion reduces elastase-
induced complexity. Indeed, analyzing the 404−420 region in
TAF4 revealed that trypsin treatment protected this region
from elastase digestion. Consequently, the complexity within
the sequential trypsin−elastase digest was reduced compared
with that of the digest from elastase alone or elastase−trypsin
(Figure 2h).
In the next step, we analyzed the eﬀect of our sequential
trypsin−elastase on the detection of cross-linked peptides. As a
proof of principle, we ﬁrst analyzed BS3 cross-linked human-
serum albumin (HSA). As expected, the increase in complexity
and the missing C-terminal charge associated with elastase
digestion adversely aﬀected the identiﬁcation of cross-linked
peptides. Although digestion of the BS3 cross-linked
complexes with trypsin allowed us to identify 152 cross-links,
digestion with elastase only led to the identiﬁcation of 42
cross-links (Figure 3a). This might be due to the increase in
the database, which is quite signiﬁcant because of the n2
behavior of the search space from cross-linked peptides.
However, adding trypsin to the elastase digest improved the
detection of cross-links, despite the increase in database size.
On the one hand, adding trypsin to the elastase-digested
peptides increased the complexity of the samples, but on the
other hand, it produced semitryptic and tryptic peptides
Figure 2. continued
lengths (<12, 13−20, and >20 residues). Peptides with a 2-fold
reduction or lower were labeled “decreased”. (h) TAF4 (residues
827−880) with the observed cleavage patterns of trypsin, elastase, and
the sequential trypsin−elastase treatment. Identiﬁed peptides are
represented as lines below the protein sequence. Data shown are the
means ± standard deviations (SD) of three independent digestions.
Trypsin, dark blue; elastase, light blue; sequential trypsin−elastase,
light green; sequential elastase−trypsin digest, dark green.
Figure 3. Impact of trypsin−elastase on the detection of cross-linked residues. (a) Number of cross-links identiﬁed for HSA. (b) Cross-links ﬁtted
into the crystal structure of HSA (monomer, PDB: 1AO6). (c) Distribution of distances between random links compared with those of the links
identiﬁed in the sequential trypsin−elastase digest. (d,e) Impact of digestion procedure on the sequence coverage of the TAF4−TAF12 complex,
with sequence coverage for TAF4 (d) and TAF12 (e) through linear peptides only. Data shown are the means ± SD of three independent
digestions. (f) Venn diagram of identiﬁed residue pairs for the trypsin and sequential trypsin−elastase digest for the TAF4−TAF12 complex. (g)
Cross-link map of the TAF4−12 complex for trypsin and sequential trypsin−elastase digest with shared links in black. Trypsin, dark blue; elastase,
light blue; sequential trypsin−elastase, light green; sequential elastase−trypsin digest, dark green.
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featuring peptides with a positive C-terminal charge. As 111
cross-links were identiﬁed with the elastase−trypsin digest, the
new peptides with tryptic C-termini seemed to have a bigger
impact than the increase in complexity. Our analysis so far
indicated that reversing the order to trypsin followed by
elastase reduces the complexity of the sample and should
therefore improve detection of cross-linked peptides. Indeed,
more cross-links (131) were identiﬁed with the trypsin−
elastase digest compared with the elastase−trypsin digest. As a
ﬁnal test of our workﬂow, we ﬁtted the detected cross-links
into the crystal structure of HSA (PDB: 1AO6, monomeric;
Figure 3b). As expected from the link-level FDR (5%), 5% of
the links derived from the trypsin−elastase digest were overly
long (Figure 3c).
Having successfully tested our workﬂow on HSA, we moved
on to analyze the TAF4−TAF12 complex. Sequence coverage
of both TAF4 and TAF12 decreased from 74 and 75% to 73
and 65%, respectively, when trypsin was replaced by elastase
(Figure 3d,e). In marked contrast, adding elastase to tryptic
peptides increased sequence coverage of TAF4 to 93% and
TAF12 to 92%. Reversing the order of digestion to elastase−
trypsin still increased the sequence coverage of TAF4 and
TAF12 to 95 and 85%. Our previous observation on the
impact of complexity and positively charged C-termini on
cross-link identiﬁcation held true for the analysis of the TAF4−
12 complex. We identiﬁed 162 cross-links with trypsin alone,
followed by 115 and 42 cross-links for trypsin−elastase and
elastase−trypsin digestion, respectively. A very small number
of cross-links (six) was detected when only elastase was used.
The cross-links determined from the sequential trypsin−
elastase digest were highly complementary to the trypsin data,
with only 59 shared out of 218 identiﬁed cross-links (Figure
3f). Importantly, the additional digestion of tryptic peptides by
elastase provided data in the previously undetected N-terminal
region of TAF4 (Figure 3g).
To test the behavior of elastase in complex mixtures, we
applied the protocol to whole-cell lysate of S. pombe. Three
characteristics of the identiﬁed peptides (peptide length,
peptide type, and amount of miscleavages) indicate that the
length of the substrate inﬂuences the activity of elastase.
Although digesting tryptic peptides with elastase reduced the
number of longer peptides, the median of all digests containing
elastase was 13 amino acids (Figure 4a). If the activity of
elastase were not inﬂuenced by the substrate size, the
distribution of tryptic, semitryptic, and elastase peptides
would be independent of the digestion order. However,
sequential trypsin−elastase digestion led to more tryptic
peptides than elastase−trypsin digestion (Figure 4b). Shorter
peptides were very poor substrates for the second enzyme.
Consequently, the ﬁrst enzyme produced the majority of the
peptides. Because of the favorable mass-spectrometric behavior
of tryptic peptides, trypsin should always be the ﬁrst enzyme
used in a sequential digestion. Unsurprisingly, a higher number
of miscleavages occurred when elastase was used in all enzyme
combinations (Figure 4c). Interestingly, treating the sample
with trypsin prior to elastase digestion increased miscleavages.
This suggests that the treatment with trypsin reduced the
available elastase sites, presumably through their “protection”
of being in smaller peptides.
The highest number, with 1377 ± 62 protein identiﬁcations,
was achieved using only trypsin (Figure 4d). Subsequent
elastase digestion reduced the numbers to 874 ± 39. Using
only elastase yielded 593 ± 6 protein identiﬁcations. The least
amount of proteins, 492 ± 115 proteins, was identiﬁed with
sequential elastase−trypsin. More of the identiﬁed semitryptic
peptides from the sequential digests had tryptic C-termini (55
± 2%). Although the diﬀerence is not as pronounced as for the
TAF4−12 complex, it is consistent with a favorable property of
a positively charged residue at the C-terminus for MS/MS
analysis. This may also explain in part the reduced
identiﬁcation numbers in the sequential digestion compared
with trypsin alone. Peptides with a nontryptic C-terminus
should be as frequent in the mixture as with a nontryptic N-
terminus. A reduced number of identiﬁcations paired with a
similar number of MS2 spectra between trypsin and sequential
digestion suggests that the challenge is in MS2. Indeed,
although the number of MS2 for the trypsin (35 203 ± 3088)
and the sequential trypsin−elastase digests (35 160 ± 3322)
were quite similar, only 31 ± 3% of the MS2 spectra from the
trypsin−elastase digest could be matched, compared with 54 ±
2% from the tryptic digest (Figure 4e). In terms of sequence
coverage, the larger number of peptides identiﬁed in the
trypsin digest also resulted in more residues being covered
Figure 4. Impact of elastase when following trypsin in a sequential
digest in S. pombe cell lysate. (a) Peptide-length distribution. (b)
Number of tryptic, semitryptic, and elastase peptides identiﬁed in
both the trypsin−elastase (light green) and elastase−trypsin digests
(dark green). (c) Distribution of miscleavages for elastase, trypsin−
elastase, and elastase−trypsin digests. (d) Number of identiﬁed
proteins. (e) Percentage of identiﬁed MS2. (f) Overlap of observed
residues by trypsin and sequential trypsin−elastase digestion. Data
shown are the means ± SD of duplicate injections from three
independent digestions. Trypsin, dark blue; elastase, light blue;
sequential trypsin−elastase, light green; sequential elastase−trypsin
digest, dark green.
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(190 261 ± 8215) than with the sequential digest (100 570 ±
10 660). However, peptides derived from the sequential digest
covered some diﬀerent regions than the tryptic peptides,
expanding the covered sequence space of trypsin by 11%
(Figure 4f).
■ CONCLUSION
Elastase digestion leading to complementary data compared
with trypsin digestion has been shown before and could be
conﬁrmed in our study.17,33 Although sequential digests have
been used before,34−36 to our knowledge elastase has not been
exploited in sequential digestion of tryptic peptides or for
CLMS. Elastase generates very complex peptide mixtures, with
many peptides having sequence overlap. Conceptually, CLMS
does not combine well with the use of elastase or other
proteases with broad cleavage speciﬁcity. The increase of
complexity and loss in sensitivity normally accompanying the
occurrence of overlapping peptides is exacerbated in cross-
linking. Every cross-linked peptide consists of two peptides and
consequently is subject to combinatorial loss. This meets an
already low abundance of cross-linked peptides. The cleavage
by trypsin prior to elastase digestion reduces the complexity
that is typically associated with elastase digestion. The cleavage
of tryptic peptides by elastase is biased toward long peptides
and increases their detection. As a result, we detect cross-links
in the diﬃcult-to-digest N-terminal region of TAF4. Our
protocol of using trypsin prior to a complementary enzyme to
enhance the performance of the complementary enzyme is also
applicable to other enzymes, as was shown recently for AspN,
GluC, and chymotrypsin.15 These gains, at least for elastase,
transfer to proteomics at large as shown by our results in S.
pombe lysate. We anticipate that our protocol will therefore
also be useful for other proteomic applications. This includes
the detection of post-translational modiﬁcations and the
analysis of transmembrane domains. The former beneﬁts
from increased sequence observation, whereas trypsin leads to
systematically large peptides in the latter.
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